We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,150 results
  1. Frontotemporal lobar degeneration

    Frontotemporal lobar degeneration (FTLD) is one of the most common causes of early-onset dementia and presents with early...

    Murray Grossman, William W. Seeley, ... John C. van Swieten in Nature Reviews Disease Primers
    Article 10 August 2023
  2. Frontotemporal lobar degeneration in the “Annual of the Pathological Autopsy Cases in Japan”

    Background

    Good accuracy for the clinical diagnosis of frontotemporal lobar degeneration (FTLD) by specialists in an early onset dementia clinic has...

    Yoshihiko Horimoto, Chikako Sato, ... Hiroshi Inagaki in Journal of Neurology
    Article 22 June 2024
  3. Synaptic density affects clinical severity via network dysfunction in syndromes associated with frontotemporal lobar degeneration

    There is extensive synaptic loss from frontotemporal lobar degeneration, in preclinical models and human in vivo and post mortem studies....

    David J. Whiteside, Negin Holland, ... James B. Rowe in Nature Communications
    Article Open access 20 December 2023
  4. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration

    Early pathological features of frontotemporal lobar degeneration (FTLD) due to MAPT pathogenic variants (FTLD-MAPT) are understudied, since...

    Lucia AA Giannini, Merel O Mol, ... Harro Seelaar in Acta Neuropathologica Communications
    Article Open access 02 August 2023
  5. TAF15 amyloid filaments in frontotemporal lobar degeneration

    Frontotemporal lobar degeneration (FTLD) causes frontotemporal dementia (FTD), the most common form of dementia after Alzheimer’s disease, and is...

    Stephan Tetter, Diana Arseni, ... Benjamin Ryskeldi-Falcon in Nature
    Article Open access 06 December 2023
  6. Increase in wasteosomes (corpora amylacea) in frontotemporal lobar degeneration with specific detection of tau, TDP-43 and FUS pathology

    Wasteosomes (or corpora amylacea) are polyglucosan bodies that appear in the human brain with aging and in some neurodegenerative diseases, and have...

    Raquel Alsina, Marta Riba, ... Jordi Vilaplana in Acta Neuropathologica Communications
    Article Open access 15 June 2024
  7. Association of cortical and subcortical microstructure with disease severity: impact on cognitive decline and language impairments in frontotemporal lobar degeneration

    Background

    Cortical and subcortical microstructural modifications are critical to understanding the pathogenic changes in frontotemporal lobar...

    Wencai Ding, Peng Ren, ... Maria Luisa Mandelli in Alzheimer's Research & Therapy
    Article Open access 21 March 2023
  8. Syndromes associated with frontotemporal lobar degeneration change response patterns on visual analogue scales

    Self-report scales are widely used in cognitive neuroscience and psychology. However, they rest on the central assumption that respondents engage...

    Rebecca S. Williams, Natalie E. Adams, ... James B. Rowe in Scientific Reports
    Article Open access 02 June 2023
  9. Heteroplasmic mitochondrial DNA mutations in frontotemporal lobar degeneration

    Frontotemporal lobar degeneration (FTLD) is a common cause of young onset dementia and is characterised by focal neuropathology. The reasons for the...

    Yu Nie, Alexander Murley, ... Patrick F. Chinnery in Acta Neuropathologica
    Article Open access 30 April 2022
  10. Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals OTUD4 in shared dysregulated signatures across pathological subtypes

    Frontotemporal lobar degeneration (FTLD) is an umbrella term describing the neuropathology of a clinically, genetically and pathologically...

    Katherine Fodder, Megha Murthy, ... Conceição Bettencourt in Acta Neuropathologica
    Article Open access 07 May 2023
  11. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration

    Frontotemporal lobar degeneration with MAPT pathogenic variants (FTLD-MAPT) has heterogeneous tau pathological inclusions postmortem, consisting of...

    Lucia A. A. Giannini, Daniel T. Ohm, ... David J. Irwin in Acta Neuropathologica
    Article Open access 06 September 2022
  12. The neurophysiological effect of NMDA-R antagonism of frontotemporal lobar degeneration is conditional on individual GABA concentration

    There is a pressing need to accelerate therapeutic strategies against the syndromes caused by frontotemporal lobar degeneration, including...

    Alistair Perry, Laura E. Hughes, ... James B. Rowe in Translational Psychiatry
    Article Open access 27 August 2022
  13. Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration

    Impaired proteostasis is associated with normal aging and is accelerated in neurodegeneration. This impairment may lead to the accumulation of...

    Sidhartha Mahali, Rita Martinez, ... Celeste M. Karch in Translational Psychiatry
    Article Open access 10 December 2022
  14. Resting state functional brain networks associated with emotion processing in frontotemporal lobar degeneration

    This study investigated the relationship between emotion processing and resting-state functional connectivity (rs-FC) of the brain networks in...

    Elisa Canu, Davide Calderaro, ... Federica Agosta in Molecular Psychiatry
    Article Open access 20 May 2022
  15. Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer’s Disease from Frontotemporal Lobar Degeneration

    Background

    Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD) are heterogeneous in their clinical presentation and underlying...

    Marion Ortner, O. Goldhardt, ... T. Grimmer in The Journal of Prevention of Alzheimer's Disease
    Article Open access 04 March 2022
  16. Plasma biomarkers increase diagnostic confidence in patients with Alzheimer’s disease or frontotemporal lobar degeneration

    Background

    The recent development of techniques to assess plasma biomarkers has changed the way the research community envisions the future of...

    Daniele Altomare, Ilenia Libri, ... Barbara Borroni in Alzheimer's Research & Therapy
    Article Open access 11 May 2024
  17. Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years

    Frontotemporal lobar degeneration (FTLD) with TDP-43-immunoreactive inclusions (FTLD–TDP) is a neurodegenerative disease associated with clinical,...

    Arenn F. Carlos, Keith A. Josephs in Journal of Neurology
    Article 23 March 2022
  18. Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration

    Background

    In the last decade, non-invasive blood-based and neurophysiological biomarkers have shown great potential for the discrimination of several...

    Alberto Benussi, Valentina Cantoni, ... Barbara Borroni in Alzheimer's Research & Therapy
    Article Open access 13 October 2022
  19. Measuring social cognition in frontotemporal lobar degeneration: a clinical approach

    Alterations in social cognition, a broad term indicating our ability to understand others and adapt our behavior accordingly, have been the focus of...

    Maria Antonietta Magno, Elisa Canu, ... Massimo Filippi in Journal of Neurology
    Article 19 November 2021
  20. Signature laminar distributions of pathology in frontotemporal lobar degeneration

    Frontotemporal lobar degeneration (FTLD) with either tau (FTLD-tau) or TDP-43 (FTLD-TDP) inclusions are distinct proteinopathies that frequently...

    Daniel T. Ohm, Katheryn A. Q. Cousins, ... David J. Irwin in Acta Neuropathologica
    Article Open access 08 January 2022
Did you find what you were looking for? Share feedback.